Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
"I expect that the daily death rate will double in the next 10 days," he said. "We'll be seeing close to 4,000 deaths a day."
https://www.cnn.com/2020/11/26/health/us-coronavirus-thursday/index.html
I think it will come out that the other 2 aren't 90%+ effective. They probably cause harm as well.
Interesting, I wonder who else will fall
https://www.nytimes.com/2020/11/25/business/coronavirus-vaccine-astrazeneca-oxford.html
Thanks Tom, you as well!
I read it as they hope to file along with completing trial by the end of the year. If they did file, fantastic!
It's a scam. There is zero interest, no volume, this company has been around for well over a decade....
Thanks Tom,
Much appreciated
What are we looking at besides a downtrend that seems to be coming together?
What they stopped the trial and deemed it unsafe. They got mm use and can't prescribe with people that need oxygen, now they can??? Ok
No, vaccines won't be available right away, and only 30% of the population will take them.
The US alone had close to 1m cases alone last week, times 4% = 40k cases. The death rate is still around 1%. The virus has mutated several times, as we are getting into flu season on top of everything. With kids coming back from college, and families spending time together for Thanksgiving. I anticipate that these numbers will increase dramatically in the US alone. The rest of the world is steadily increasing as well, several countries in lockdown until December. I think there will be a place for Leronlimab.
I only care of they announce leronlimab. I could care less if they are approving nonsense treatments that cause false hope and cost the tax payers
The point was, our directors are getting way more than multi billion companies are offering.
So the CEO of pfizer at 60% and at $44 is only $5.6m. And Nader sold his and got $12m. I think we're over paying with benefit shares.... They actually have revenue
I believe that was only on the 700mg dose, which they are re-doing. The UK will only be for 350mg.
Agreed,
We need to focus on 2 things, finishing the S/C trial and submitting the BLA, all other distractions and trials need to be put on the back burner. Mahboob is going to be focused on the BLA, if he completes it for one country it should be good for all I would suspect. I would focus on 350mg which is what the trial was set up for and leave the rest along.
Thank you as always Tom. I think that support level will be a huge ask. I see 2 scenarios playing out tomorrow. We along with the other therapeutics get a bump from this new of Eli Lilly, like the other vaccines did today, or we're going below $2 tomorrow, as bounced off $2.03 several times today, it may not take much. I hope to see the bounce.
They can still run the covid trial, mahboob is focused on HIV bla, had nothing to do with covid.
There is supposed to be a meeting with Canada tomorrow, like the UK, they will talk about submitting the BLA for HIV, and possibly Covid.
I find it pretty encouraging that the company has been in contact with Janet Woodcock, and the OWS. They are fully aware of Leronlimab. It's only matter of time.
I think some of the blame lies with the company. Why couldn't they have submitted the BLA to the UK 2 years ago at 350mg while conducting the 525mg and 750mg additional tests?
The Covid BLA? Where did you see/hear that? As far as I know we were cleared to submit the HIV BLA for 350mg. I don't think the company can even produce a Covid BLA at this point as we don't have access to the trial data.
I'm confident that the new CSO will get it done. He's successfully completed 16 BLAs, and has worked for BP's in the past. I think we're now in great hands.
Who's to say the new face they brought in won't complete the bla for 350mg and submit to the FDA as well. Our trial was set up for 350mg, we completed it as such. The FDA asked for higher dosing but was not part of original trial layout. We have a viable trial complete at 350mg. It proves safe and twice as efficient as standard care. Mahboob has successfully submitted 16 BLAs. Let's see what happens
It's currently dropped below
Yes very promising. The ability to cross the BBB is a HUGE benefit for this already safe drug. IMO we really need a BP partner for funding as well as trials and politics.
I thought eua was only granted when there was no drug previously approved?
Can we even get EUA now that they have received full approval?
Every time there is a history lesson...there is nothing good to follow.
We already had a meeting on 9-2 with them...
Don't forget we have a meeting with the MHRA on the 22nd. Our 350mg combo trial is solid, and should have been approved years ago.
I agree that we do not have the capacity for numerous trials. We need to focus on HIV, and continue the CD-12 trial if EUA is not granted. We still have a basket trial going on as well. We have limited funding, and are having a hard time with enrollment, this is the time to prioritize.
So what are your thought about this path we've set ourselves on with the Philippines?